|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Arrhythmia | |||||
| Cardiovascular Diseases | |||||
| Coronary Disease | |||||
| Death, Sudden, Cardiac | |||||
| Heart Diseases | |||||
| Myocardial Ischemia | |||||
| Tachycardia, Ventricular | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Arrhythmias, Cardiac | |||||
| Death, Sudden | |||||
| Ischemia | |||||
| Tachycardia | |||||
| 3 | More general conditions related to this trial | ||||
| Death | |||||
| Heart Arrest | |||||
| Pathologic Processes | |||||
| Vascular Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| electrophysiology | |||||
| anti-arrhythmia agents | |||||
| defibrillators, implantable | |||||
| 5 | Sponsors listed in this trial | ||||
| National Heart, Lung, and Blood Institute (NHLBI) | |||||